NCT07749391

Brief Summary

Suicide is a leading cause of death in the United States and around the world. Individuals at high-risk for suicide are heterogenous. Despite this heterogeneity, interventions are often developed and tested assuming that suicidal thoughts and behaviors are caused by common factors. The proposed research uses person-specific idiographic quantitative techniques to inform intervention development. In the first aim (N = 10), we will refine a brief, personalized, and adjunctive intervention to help reduce emotional distress, increase effective emotion regulation strategies, and decrease suicidal thoughts. Participants will be recruited from the university counseling center. They will then complete six weeks of surveys delivered to their smartphones (5x/day), answering questions about their emotional states, emotion regulation, and suicidal thoughts and behaviors. After the first 14 dats, individual participant data will then be analyzed using idiographic techniques (n=1) to identify person-specific correlates of suicidal thoughts. Participants will meet with a coach to complete a risk assessment, review idiographic data, learn personally tailored skills from dialectical behavior therapy, and finish a personalized safety plan. Participants will be offered up to six sessions. Between sessions, participants will continue to complete surveys to measure progress and update idiographic models. We will obtain feedback from these initial participants and refine the intervention. We will then pilot test the intervention in an open-label non-randomized trial (N = 40), again recruiting students from the university counseling center. We anticipate the intervention will be feasible and acceptable, and that participants' emotional distress will decrease, effective emotion regulation strategies increase, and suicidal thoughts decrease by the end of the six-week intervention. We hope to test this intervention in a sequential multiple-assignment randomized trial. The proposed research marks an initial attempt at developing personalized interventions based on person-specific correlates of suicidal thoughts.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
May 2024Sep 2026

Study Start

First participant enrolled

May 23, 2024

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 6, 2026

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2026

Last Updated

August 6, 2026

Status Verified

July 1, 2026

Enrollment Period

2.3 years

First QC Date

July 31, 2026

Last Update Submit

July 31, 2026

Conditions

Keywords

personalized medicinedialectical behavior therapysafety planningemotion regulationclinical psychologypsychiatry

Outcome Measures

Primary Outcomes (2)

  • Suicidal Thoughts and Behaviors

    Suicidal ideation and behavior assessed via the Columbia-Suicide Severity Rating Scale (C-SSRS), a structured interview administered by a trained assessor. The C-SSRS rates suicidal ideation along a severity continuum (from passive wish to be dead through active ideation with specific plan and intent) and separately captures suicidal behavior (actual, interrupted, and aborted attempts; preparatory acts; and non-suicidal self-injury). Ideation intensity (frequency, duration, controllability, deterrents, reasons for ideation) is also assessed.

    Baseline, 6-weeks, 12-weeks

  • Suicidal Ideation

    Suicidal ideation severity assessed via the Modified Scale for Suicide Ideation (MSSI), a clinician-administered rating scale adapted from Beck's original Scale for Suicide Ideation (SSI). The MSSI extends the original SSI with additional items assessing components such as desire to live, desire to die, deterrents to suicide, and courage/competence to attempt, yielding a broader assessment of ideation severity and risk than the original scale.

    Baseline, 6-weeks, 12-weeks

Secondary Outcomes (2)

  • Change in Negative Emotion Intensity

    Baseline through 6-weeks

  • Change in Adaptive Emotion Regulation Strategy Use

    Baseline through 6-weeks

Study Arms (1)

PRECISE

EXPERIMENTAL

All enrolled participants receive the PRECISE intervention, a brief (up to six sessions over six weeks), personalized, EMA-informed adjunctive intervention for suicidal thoughts and behaviors, delivered via secure videoconferencing by trained coaches. Sessions incorporate idiographic analysis of participants' own ecological momentary assessment (EMA) data to identify personalized correlates of suicidal thoughts, which inform functional analysis, safety planning, and targeted emotion regulation skills coaching. Each session begins with a suicide risk assessment; participants at acute risk complete a structured risk management protocol. Participants also complete smartphone-based EMA surveys multiple times daily throughout the six-week intervention period.

Behavioral: PRECISE

Interventions

PRECISEBEHAVIORAL

All enrolled participants receive the PRECISE intervention, a brief (up to six sessions over six weeks), personalized, EMA-informed adjunctive intervention for suicidal thoughts and behaviors, delivered via secure videoconferencing by trained coaches. Sessions incorporate idiographic analysis of participants' own ecological momentary assessment (EMA) data to identify personalized correlates of suicidal thoughts, which inform functional analysis, safety planning, and targeted emotion regulation skills coaching. Each session begins with a suicide risk assessment; participants at acute risk complete a structured risk management protocol. Participants also complete smartphone-based EMA surveys multiple times daily throughout the six-week intervention period.

PRECISE

Eligibility Criteria

Age18 Years - 26 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-26 years Endorsement of active suicidal ideation on the Columbia-Suicide Severity Rating Scale (C-SSRS) (score \>2, or past-month thoughts of killing self) English fluency Willingness to provide contact information for a key support person to be contacted as part of the study's risk and safety plan

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stein Clinical Research Building

La Jolla, California, 92093, United States

Location

MeSH Terms

Conditions

Suicidal IdeationBehaviorEmotional Regulation

Condition Hierarchy (Ancestors)

SuicideSelf-Injurious BehaviorBehavioral SymptomsSelf-ControlSocial Behavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All participants receive the PRECISE intervention in a single-arm, open-label design. The study is conducted in two sequential, non-randomized phases: an initial feasibility phase (n=5) to refine the intervention, followed by a pilot phase (n=30) using the refined intervention protocol to further evaluate feasibility, acceptability, and preliminary outcomes. There is no control or comparison group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 31, 2026

First Posted

August 6, 2026

Study Start

May 23, 2024

Primary Completion (Estimated)

September 3, 2026

Study Completion (Estimated)

September 3, 2026

Last Updated

August 6, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data, including baseline assessment measures and aggregated ecological momentary assessment (EMA) data, will be made publicly available via GitHub (https://github.com/kskuehn) following completion of the primary analyses and manuscript preparation. Data will be stripped of direct identifiers prior to posting. This data sharing plan is described in the study's informed consent document.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Mid-September 2026. Will be available indefinitely
Access Criteria
Open access
More information

Locations